ERISA Suit Over GSK's Stiefel Acquisition To Proceed
A federal judge has greenlighted the majority of a class action accusing Stiefel Laboratories Inc. of significantly undervaluing its stock when it persuaded employees to resell their shares to the company...To view the full article, register now.
Already a subscriber? Click here to view full article